Highly efficient selection of tumor neoantigens improves therapeutic cancer vaccine efficacy by Annie De Groot | Nov 12, 2019 | 0 comments Highly efficient selection of tumor neoantigens improves therapeutic cancer vaccine efficacy Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website